ImmuCell reports preliminary Q4 results
Source: SeekingAlpha
2026-01-08 16:28:29 ET
More on ImmuCell
- ImmuCell Corporation (ICCC) Q3 2025 Earnings Call Transcript
- ImmuCell Corporation: At A Major Inflection Point
- ImmuCell signals operational excellence and targets $30M annual production capacity amid management transition
- mmuCell appoints Olivier te Boekhorst as new CEO
- Seeking Alpha’s Quant Rating on ImmuCell
Read the full article on Seeking Alpha
For further details see:
ImmuCell reports preliminary Q4 results
ImmuCell Corporation
NASDAQ: ICCC
ICCC Trading
-0.79% G/L:
$6.275 Last:
2,985 Volume:
$6.30 Open:
ICCC Latest News
March 04, 2026 04:05:00 pm
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
February 18, 2026 08:37:10 am
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
January 08, 2026 04:05:00 pm
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
January 07, 2026 08:10:57 am
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
ICCC Stock Data
$60,757,363
6,377,325
3.65%
14
N/A
Biotechnology & Life Sciences
Healthcare
US
Portland
